- Report
- August 2024
- 79 Pages
Global
From €3228EUR$3,495USD£2,700GBP
- Report
- June 2025
- 150 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- June 2025
- 134 Pages
Global
From €4480EUR$4,850USD£3,747GBP
- Report
- April 2023
- 94 Pages
Global
From €3500EUR$4,059USD£3,030GBP
Acute Coronary Syndrome (ACS) is a term used to describe a range of conditions caused by a sudden decrease in blood flow to the heart. This can lead to chest pain, heart attack, and other cardiovascular complications. ACS is a major cause of death and disability worldwide.
The ACS drug market is a subset of the larger cardiovascular drug market. It includes drugs used to treat ACS, such as antiplatelet agents, anticoagulants, and statins. These drugs are used to reduce the risk of further complications and improve patient outcomes. Additionally, drugs used to treat the symptoms of ACS, such as pain medications, are also included in this market.
The ACS drug market is highly competitive, with many large pharmaceutical companies offering a range of products. Some of the major players in this market include Pfizer, Merck, Sanofi, Bristol-Myers Squibb, and Novartis. Show Less Read more